The risk of death due to cardiovascular diseases, coronary heart disease (CHD) and stroke in Brazil has been declining since the 1980s.
Since the 2000s, the coverage of the Brazilian national mortality surveillance system has increased, and the quality of death certification has improved. This has yielded a higher proportion of accurate diagnoses. Thus, for example, there are now fewer cases of mortality due to "heart failure" (a garbage code) and more of CHD; and fewer cases of mortality due to "hypertension" (also a garbage code) and more of stroke. 5 I hypothesized that this improvement in quality ought to alter the real trend of mortality due to CHD and stroke. To verify this possibility, I used information from the Global Burden of Disease study, which corrects these two phenomena (i.e. increased coverage plus improved quality) through new data. 6 To analyze differences in trends from 1990 to 2017, the annual percentage change (APC) was calculated by applying the Joinpoint regression software.
7 Figure 1 shows that the reductions in age-adjusted mortality rates for men (A) and women (B) have been declining over the course of this period, which comprises almost three decades. However, visually, it is not possible to conclude whether the rates have flattened or have continued to fall over the last five years (2013-17). Table 1 shows the APCs according to sex and type of disease. For all cardiovascular diseases, the decline has been maintained for men, but not for women. Indeed, the flattening of the cardiovascular disease rate trend is due to the trend observed for stroke mortality, but not for CHD. The reductions in deaths due to CHD have occurred among both men and women. However, the year-on-year decrease in CHD has become progressively smaller over the last few years, compared with the situation when these observations began.
This "almost stagnated" pattern of mortality rates for stroke and all cardiovascular diseases, but not for coronary heart disease, should serve to alert epidemiologists to the need to continue studying the determinants of cardiovascular diseases. 
